COMMUNIQUÉS West-GlobeNewswire

Nexstim Plc Launches Presence in Asia with Distribution Agreement of its SmartFocus(TM) TMS system to Access Hong Kong Market
03/10/2018
Nexstim Plc Launches Presence in Asia with Distribution Agreement of its SmartFocus(TM) TMS system to Access Hong Kong Market First NBT ® system for applications in depression already installed in Hong Kong Press [...]
Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018
03/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterial agents to address multi- [...]
Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
03/10/2018
Medical facility becomes first in South Dakota to offer intraoperative radiation therapy with the revolutionary Xoft System to improve patient care NASHUA, N.H. and SIOUX FALLS, S.D., Oct. 03, 2018 (GLOBE NEWSWIRE) -- [...]
Forty Seven Inc. Appoints Leading Experts in Immuno-Oncology to its Scientific Advisory Board (SAB)
03/10/2018
MENLO PARK, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV) today announced the formation of its Scientific Advisory Board (SAB), comprised of four leading scientists in the fields of [...]
Robert Foster Appointed Acting Chief Executive Officer of ContraVir Pharmaceuticals, Inc.
03/10/2018
EDISON, N.J., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Entasis Therapeutics to Present on ETX2514SUL at IDWeek 2018
03/10/2018
WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced [...]
CTD announces encouraging top-line data from two ongoing clinical trials of Trappsol® Cyclo™ administered intravenously in Niemann Pick Disease Type C (NPC)
03/10/2018
ALACHUA, Fla., Oct. 03, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced initial [...]
Altimmune Closes on $16.9 Million in Funding
03/10/2018
$12 million underwritten public offering closed October 2 $4.9 million registered direct offering closed September 26 GAITHERSBURG, Md., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage [...]
Radius Health Announces Latest 2019 Medicare Part D Coverage for TYMLOS® (abaloparatide) Injection
03/10/2018
TYMLOS is now covered for 64% of Medicare Part D insured lives WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is [...]
Precipio Launches HemeScreen™, a Disruptive, Proprietary Molecular Test for Hematologic Cancers
03/10/2018
Impacts a $100M annual US laboratory market by reducing testing costs through a simple, screening assay NEW HAVEN, Conn., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: [...]
Results from a large observational study combining the National Early Warning Score (NEWS) with suPAR documents that suPARnostic® improves risk stratification in acute medical patients
03/10/2018
Press Release Birkerød, 3 October 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, today announces that data from a study [...]
Biogen to Present Data from its Neurology Pipeline at the 2018 International Congress of Parkinson’s Disease and Movement Disorders (MDS)
03/10/2018
CAMBRIDGE, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Data to be presented from the BIIB092 program for progressive supranuclear palsy and BIIB054 program for Parkinson’s disease highlight Biogen’s commitment to [...]
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors
03/10/2018
SHANGHAI, China and CUPERTINO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
03/10/2018
RAMSEY, N.J. and MARIETTA, Ga., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, manufactures [...]
Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting
03/10/2018
SALT LAKE CITY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that four studies on Vectra ® will be featured at the American College of [...]
Oasmia Presents Positive Efficacy and Safety Data for Doxophos Vet in Treatment of Naïve Dogs with Lymphoma
03/10/2018
Overall response rate data from the (RXE) Phase II study conducted in the US and Sweden met its primary end points and treatment with Doxophos Vet was generally well tolerated. Oasmia’s assessment is that the positive [...]
Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products
03/10/2018
Research focused on supporting and validating Emerald’s intellectual property and development of its pipeline of proprietary cannabis products VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health [...]
Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018
03/10/2018
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018 Ridinilazole in Development to Treat C. difficile Infection and Reduce Recurrent [...]
Aclaris Therapeutics Announces Poster Presentations at 2018 American Society for Dermatologic Surgery Annual Meeting and Fall Clinical Dermatology Conference
03/10/2018
WAYNE, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]

Pages